Axel Gerdtsson

697 citations
21 papers · 294 indexed · h-index 5
Topics
Prostate Cancer Diagnosis and Treatment (8 papers)Testicular diseases and treatments (6 papers)Prostate Cancer Treatment and Research (6 papers)

In The Last Decade

Axel Gerdtsson

18 papers receiving 288 citations

Peers

Axel Gerdtsson
Comparison fields: 5 of 47
  • Pulmonary and Respiratory Medicine 226
  • Surgery 119
  • Oncology 71
  • Rheumatology 48
  • Molecular Biology 28
Replace Norio Meguro with:
Norio Meguro Japan
Eric A. Klein United States
Mahendra Pal India
Jacques Irani France
Rachel Jia United States
Kelly E. Maloney United States
Jessica D. Lubahn United States
Mark Fallick United States
A Manganelli Italy
Frederik König Germany
Axel Gerdtsson relative to Norio Meguro Japan Norio Meguro's profile →
Citations per field
00.5×10×15×20×23×
Norio Meguro · 1×
Citations per year

Countries citing papers authored by Axel Gerdtsson

Since Specialization
Citations

This map shows the geographic impact of Axel Gerdtsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Gerdtsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Gerdtsson more than expected).

Fields of papers citing papers by Axel Gerdtsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Gerdtsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Gerdtsson. The network helps show where Axel Gerdtsson may publish in the future.

Co-authorship network of co-authors of Axel Gerdtsson

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Gerdtsson. A scholar is included among the top collaborators of Axel Gerdtsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Gerdtsson. Axel Gerdtsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 1
5 1
6 0
7 1
8 2
9 1
10 4
11 1
12 2
13 15
14 36
15 2
16 37
17 13
18 173
19 1
20 2

About Axel Gerdtsson

Axel Gerdtsson is a scholar working on Urology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 294 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (8 papers), Testicular diseases and treatments (6 papers) and Prostate Cancer Treatment and Research (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (226 citations), Rheumatology (48 citations) and Surgery (119 citations). Axel Gerdtsson has collaborated with scholars based in Sweden, United States and Norway. Frequent co-authors include Andrew J. Vickers, David Ulmert, Hans Lilja, Jonas Manjer, Anders Bjartell, Peter T. Scardino, Anna M. Dahlin, Thomas Björk, Peter M. Nilsson and Daniel D. Sjoberg. Their work appears in journals such as Journal of Clinical Oncology, BMJ and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026